Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study

Abstract Men are more vulnerable to ischemic heart disease (IHD) than women, possibly due to testosterone. Correspondingly, sex hormone binding globulin (SHBG) which lowers circulating testosterone might protect men against IHD. SHBG may also affect IHD independent of testosterone, which has not pre...

Full description

Bibliographic Details
Main Authors: Jie V. Zhao, C. Mary Schooling
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-02510-w
_version_ 1818833992426717184
author Jie V. Zhao
C. Mary Schooling
author_facet Jie V. Zhao
C. Mary Schooling
author_sort Jie V. Zhao
collection DOAJ
description Abstract Men are more vulnerable to ischemic heart disease (IHD) than women, possibly due to testosterone. Correspondingly, sex hormone binding globulin (SHBG) which lowers circulating testosterone might protect men against IHD. SHBG may also affect IHD independent of testosterone, which has not previously been examined. To assess the sex-specific role of SHBG in IHD, in univariable Mendelian randomization (MR), we used sex-specific, genome-wide significant genetic variants to predict SHBG, and examined their association with IHD in the UK Biobank. We also replicated using genetic instruments from Japanese men and applied to Biobank Japan. To assess the role of SHGB independent of testosterone in men, we used multivariable MR controlling for testosterone. Genetically predicted SHBG was associated with lower IHD risk in men [odds ratio (OR) 0.78 per standard deviation, 95% confidence interval (CI) 0.70 to 0.87], and the association was less clear in women. The estimates were similar in Japanese. The inverse association remained after controlling for testosterone in men (OR 0.79, 95% CI 0.71 to 0.88). SHBG might lower the risk of IHD in men, with a role independent of testosterone. Exploring intervention strategies that increase SHBG is important for targeting IHD treatments.
first_indexed 2024-12-19T02:27:44Z
format Article
id doaj.art-c20e99f71bda4605af8709c2718f23a4
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T02:27:44Z
publishDate 2021-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c20e99f71bda4605af8709c2718f23a42022-12-21T20:39:53ZengNature PortfolioScientific Reports2045-23222021-11-011111810.1038/s41598-021-02510-wGenetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization studyJie V. Zhao0C. Mary Schooling1School of Public Health, Li Ka Shing, Faculty of Medicine, The University of Hong KongSchool of Public Health, Li Ka Shing, Faculty of Medicine, The University of Hong KongAbstract Men are more vulnerable to ischemic heart disease (IHD) than women, possibly due to testosterone. Correspondingly, sex hormone binding globulin (SHBG) which lowers circulating testosterone might protect men against IHD. SHBG may also affect IHD independent of testosterone, which has not previously been examined. To assess the sex-specific role of SHBG in IHD, in univariable Mendelian randomization (MR), we used sex-specific, genome-wide significant genetic variants to predict SHBG, and examined their association with IHD in the UK Biobank. We also replicated using genetic instruments from Japanese men and applied to Biobank Japan. To assess the role of SHGB independent of testosterone in men, we used multivariable MR controlling for testosterone. Genetically predicted SHBG was associated with lower IHD risk in men [odds ratio (OR) 0.78 per standard deviation, 95% confidence interval (CI) 0.70 to 0.87], and the association was less clear in women. The estimates were similar in Japanese. The inverse association remained after controlling for testosterone in men (OR 0.79, 95% CI 0.71 to 0.88). SHBG might lower the risk of IHD in men, with a role independent of testosterone. Exploring intervention strategies that increase SHBG is important for targeting IHD treatments.https://doi.org/10.1038/s41598-021-02510-w
spellingShingle Jie V. Zhao
C. Mary Schooling
Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
Scientific Reports
title Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
title_full Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
title_fullStr Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
title_full_unstemmed Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
title_short Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study
title_sort genetically predicted sex hormone binding globulin and ischemic heart disease in men and women a univariable and multivariable mendelian randomization study
url https://doi.org/10.1038/s41598-021-02510-w
work_keys_str_mv AT jievzhao geneticallypredictedsexhormonebindingglobulinandischemicheartdiseaseinmenandwomenaunivariableandmultivariablemendelianrandomizationstudy
AT cmaryschooling geneticallypredictedsexhormonebindingglobulinandischemicheartdiseaseinmenandwomenaunivariableandmultivariablemendelianrandomizationstudy